INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

24,510 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
19
HM
Hugh MiltonEVP, Sales
VIKViking Holdings Ltd
Open-market sale · 10b5-1 plan
SELL$1.80M
20.0K sh
Nov 4, 2026Nov 6, 2026
Page 9 of 613
← PrevNext →
traded Nov 4, 2026
+2d
SEC Form 4

Evidence

19
PK
Patel Sanj KDirector, CHAIRMAN & CEO
KNSAKiniksa Pharmaceuticals International, plc
Open-market sale · 10b5-1 plan
SELL$1.06M
11.3K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

19
PK
Patel Sanj KDirector, CHAIRMAN & CEO
KNSAKiniksa Pharmaceuticals International, plc
Open-market sale · 10b5-1 plan
SELL$2.85M
29.8K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

19
GC
Goldberg ChenEVP, Product & Engineering
CRWVCoreWeave, Inc.
Open-market sale
SELL$32K
695 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

19
PK
Patel Sanj KDirector, CHAIRMAN & CEO
KNSAKiniksa Pharmaceuticals International, plc
Open-market sale · 10b5-1 plan
SELL$2.59M
26.9K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

19
EM
Ehrlichman MattDirector, CEO, CHAIRMAN AND FOUNDER, 10% Owner
PRCHPorch Group, Inc.
Open-market sale · 10b5-1 plan
SELL$120K
5,701 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

18
DP
DIRK VAN DE PUTDirector, Chief Executive Officer
MDLZMondelez International, Inc.
Open-market sale · 10b5-1 plan
SELL$7.37M
108.4K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

18
BS
BENJAMIN C SINGERChief Legal Officer; Secretary
PCORPROCORE TECHNOLOGIES, INC.
Open-market sale · 10b5-1 plan
SELL$194K
2,586 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

18
KM
Kansal MohitChief Payments Officer
FLYWFlywire Corp
Open-market sale · 10b5-1 plan
SELL$127K
6,053 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

18
ZM
Zerbe Robert L MdDirector
VCELVericel Corp
Open-market sale · 10b5-1 plan
SELL$129K
2,500 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

17
CW
Chatterjee WhitneyChief Legal Officer
APOApollo Global Management, Inc.
Open-market sale
SELL$41K
339 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

17
MK
McCulloch KevinSee Remarks
XERSXeris Biopharma Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$312K
25.0K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

17
BT
Brown Tice10% Owner
EMPDEmpery Digital Inc.
Open-market sale
SELL$1,193
500 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

17
Saba Capital Management, L.P.10% Owner
PDXPIMCO Dynamic Income Strategy Fund
Open-market sale
SELL$85K
4,172 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

17
PC
Pitigoi CosminChief Financial Officer
FLYWFlywire Corp
Open-market sale · 10b5-1 plan
SELL$301K
13.9K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

17
OP
O'Day Daniel PatrickDirector, Chairman & CEO
GILDGILEAD SCIENCES, INC.
Open-market sale · 10b5-1 plan
SELL$17.98M
102.6K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

16
DK
Dai KunDirector, Chief Executive Officer
UXINUxin Ltd
Open-market purchase · 10b5-1 plan
BUY$7,216
8,307 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

16
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$321K
562 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

16
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$334K
585 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

16
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$311K
539 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

16
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$262K
462 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

16
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$337K
560 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

16
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$407K
720 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

16
RA
Rothblatt Martine ADirector, Chairperson & CEO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$293K
520 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

15
CR
Corbin Charles R. Jr.See Remarks
HGVHilton Grand Vacations Inc.
Open-market sale · 10b5-1 plan
SELL$838K
19.6K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

15
TF
Tan FionaChief Technology Officer
WWayfair Inc.
Open-market sale · 10b5-1 plan
SELL$1.00M
8,000 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

15
PJ
Peters William JDirector, CFO, EVP & TREASURER
AMPHAmphastar Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$448K
16.0K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

15
KT
Kelley Shannon TGeneral Counsel
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$431K
1,077 sh
Nov 6, 2026Nov 6, 2026
traded Nov 6, 2026
+0dSEC Form 4

Evidence

14
TS
Tamari ShaharDirector, COO
GLBEGlobal-E Online Ltd.
Open-market sale · 10b5-1 plan
SELL$627K
14.0K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

14
JB
Jackson BenjaminPresident
ICEIntercontinental Exchange, Inc.
Open-market sale · 10b5-1 plan
SELL$71K
400 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

14
TS
Tamari ShaharDirector, COO
GLBEGlobal-E Online Ltd.
Open-market sale · 10b5-1 plan
SELL$594K
13.4K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

14
FD
Fairbank Richard DDirector, Chairman and CEO
COFCAPITAL ONE FINANCIAL CORP
Open-market sale · 10b5-1 plan
SELL$2.01M
9,942 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

14
FD
Fairbank Richard DDirector, Chairman and CEO
COFCAPITAL ONE FINANCIAL CORP
Open-market sale · 10b5-1 plan
SELL$5.01M
24.6K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

14
FD
Fairbank Richard DDirector, Chairman and CEO
COFCAPITAL ONE FINANCIAL CORP
Open-market sale · 10b5-1 plan
SELL$1.67M
7,798 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

14
FD
Fairbank Richard DDirector, Chairman and CEO
COFCAPITAL ONE FINANCIAL CORP
Open-market sale · 10b5-1 plan
SELL$3.79M
18.8K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

14
FD
Fairbank Richard DDirector, Chairman and CEO
COFCAPITAL ONE FINANCIAL CORP
Open-market sale · 10b5-1 plan
SELL$1.09M
5,454 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

14
FD
Fairbank Richard DDirector, Chairman and CEO
COFCAPITAL ONE FINANCIAL CORP
Open-market sale · 10b5-1 plan
SELL$1.07M
5,315 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

14
FD
Fairbank Richard DDirector, Chairman and CEO
COFCAPITAL ONE FINANCIAL CORP
Open-market sale · 10b5-1 plan
SELL$1.05M
4,929 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

14
DN
Debbi NirDirector, President
GLBEGlobal-E Online Ltd.
Open-market sale · 10b5-1 plan
SELL$797K
17.9K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

14
PC
Pitigoi CosminChief Financial Officer
FLYWFlywire Corp
Open-market sale · 10b5-1 plan
SELL$122K
5,916 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence